Cargando…
The National Heart, Lung, and Blood Institute Small Business Program: A Comprehensive Ecosystem for Biomedical Product Development
Small companies working to develop products in the cardiovascular space face numerous challenges, from regulatory, intellectual property, and reimbursement barriers to securing funds to keep the lights on and reach the next development milestone. Most small companies that spin out from universities...
Autor principal: | Marek, Kurt W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457156/ https://www.ncbi.nlm.nih.gov/pubmed/28580435 http://dx.doi.org/10.1016/j.jacbts.2016.08.001 |
Ejemplares similares
-
How to Start a Biomedical Device Company: Physicians Can Lead the Team Effort
por: DiMaio, J. Michael, et al.
Publicado: (2017) -
Expanding Patient Access to Investigational Drugs: Single Patient Investigational New Drug and the “Right to Try”
por: Van Norman, Gail A.
Publicado: (2018) -
Expanding Patient Access to Investigational New Drugs: Overview of Intermediate and Widespread Treatment Investigational New Drugs, and Emergency Authorization in Public Health Emergencies
por: Van Norman, Gail A.
Publicado: (2018) -
Overcoming the Declining Trends in Innovation and Investment in Cardiovascular Therapeutics: Beyond EROOM’s Law
por: Van Norman, Gail A.
Publicado: (2017) -
Entrepreneurialism in the Translational Biologic Sciences: Why, How, and However
por: Bristow, Michael R., et al.
Publicado: (2018)